LCTX Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Lineage Cell Therapeutics Inc

Watchlist Manager

Watchlist

Price: 381.6 ILS 4.52% Market Closed

Market Cap: ₪301.8m

L	Lineage Cell Therapeutics Inc TASE:LCTX	US
	Ameriprise Financial Inc NYSE:AMP	US
	United Rentals Inc NYSE:URI	US
	Afya Ltd NASDAQ:AFYA	BR
S	Sierra Bancorp NASDAQ:BSRR	US
	New China Life Insurance Co Ltd F:NCL	CN
	Quantum Computing Inc NASDAQ:QUBT	US
	Crescent Biopharma Inc F:C68	US
I	Impianti SpA MIL:MPT	IT
	Brandywine Realty Trust NYSE:BDN	US

Profitability Summary

Lineage Cell Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

99%

Strong 3Y Average Gross Margin

95%

Gross Margin is Increasing

94% > 99%

Negative Operating Margin

-150%

Negative 3Y Average Operating Margin

-249%

Operating Margin is Increasing

-192% > -150%

Negative Net Margin

-436%

Negative 3Y Average Net Margin

-312%

Declining Net Margin

-199% > -436%

Negative Free Cash Flow Margin

-134%

Negative 3Y Average Free Cash Flow Margin

-267%

Free Cash Flow Margin is Increasing

-275% > -134%

Negative ROE

-103%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-37%

ROIC is Increasing

-35% > -34%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.